B

Serial Number 97470839
733

Registration Progress

Application Filed
Jun 22, 2022
Under Examination
Mar 14, 2023
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered

Trademark Image

B

Basic Information

Serial Number
97470839
Filing Date
June 22, 2022
Published for Opposition
January 17, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
733
Status Date
Mar 5, 2025
Application
Pending
Classes
005 042

Rights Holder

BridgeBio Pharma, Inc.

03
Address
3160 Porter Dr.
Palo Alto, CA 94304

Ownership History

BridgeBio Pharma, Inc.

Original Applicant
03
Palo Alto, CA

BridgeBio Pharma, Inc.

Owner at Publication
03
Palo Alto, CA

Legal Representation

Attorney
Jessica L. Rothstein

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Sep 12, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 6, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 5, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 8, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 8, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 8, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 11, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 11, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 11, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 13, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 13, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 11, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 12, 2022 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 11, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Class 042
Pharmaceutical research and development services

Additional Information

Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
BRIDGEBIO; BRIDGE BIO

Classification

International Classes
005 042